Trial Information

Summary: Clinical Research Study Available for People Diagnosed with Multiple Sclerosis

Purpose:
Doctors and researchers are now conducting an MS research study of an FDA-approved medication to determine its safety and effectiveness in suppressing relapse rates compared to two FDA-approved medications.

Why you should call today:

• If you qualify for the study, you will be under the care of a local neurologist, and will receive study-related medical examinations, laboratory tests and study medication - at no financial cost to you.

You may be eligible for this studyt if you…

• Are 18 to 50 years of age
• Have been diagnosed with relapsing Mulitiple Sclerosis
• Are using Betaseron® 250 mcg or Rebif® 44 mcg to treat your MS

You cannot participate in this study if you…

• Have previously been treated with Copaxone®

Time commitment:
Your participation will last 3 years. During that time, participants will visit the local research site 14 times (about once every 3 months).

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:13 AM